文献速递类风湿关节炎

生物制剂治疗的类风湿关节炎患者中患者报告结局对病假的影响比客观炎症指标更重要

Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-01

基于瑞典南部关节炎治疗组登记2005至2011年941例生物制剂治疗的类风湿关节炎患者5,118次访视数据,分析各非复合疾病活动度指标与随后一个月病假天数的关联。结果显示患者疼痛评估和疾病活动度VAS评分与后续病假关联最强,客观指标(肿胀关节数、红细胞沉降率、C反应蛋白)影响较小,提示针对工作损失时应更关注主观指标。

要点

  • 患者疼痛VAS和疾病活动度VAS与随后一个月病假天数关联最强,不受基线病假状态影响。
  • 客观指标(肿胀关节数、红细胞沉降率、C反应蛋白)对病假的影响普遍小于主观指标。
  • 作者认为针对工作损失进行干预时,应更关注主观疾病活动度指标。

核心结论

  • 在生物制剂治疗的类风湿关节炎患者中,较主观的疾病活动度指标对病假的影响大于较客观的指标,作者认为针对工作损失或减少工作损失的干预应更关注主观指标。

研究设计与样本

  • 观察性研究,数据来自瑞典南部关节炎治疗组登记,纳入2005至2011年工作年龄(<65岁)生物制剂治疗的类风湿关节炎患者的访视资料,共941例患者5,118次访视。
  • 采用调整的独立广义估计方程回归模型分析各次访视时非复合疾病活动度指标与随后一个月病假天数的关联,并按访视前一个月病假状态(无、部分、完全病假)分层。
  • 结果以标准化beta系数呈现以便比较。

主要发现

  • 在可改变的(modifiable)非复合疾病活动度指标中,患者疼痛VAS和疾病活动度VAS与随后病假的关联最强,不论基线病假状态如何。
  • 总体而言,较客观的指标(肿胀关节数、红细胞沉降率、C反应蛋白)对病假的影响小于较主观的指标(患者疼痛VAS、整体VAS评分、评估者5级Likert疾病活动度整体评估、压痛关节数)。

临床怎么用

  • 作者认为,针对工作损失或为减少工作损失而进行干预时,应更关注主观疾病活动度指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the impact of common noncomposite disease activity measures on sick leave in biologics-treated patients with rheumatoid arthritis (RA). METHODS: Data from study visits by biologics-treated RA patients of working age (<65 years) in the observational South Swedish Arthritis Treatment Group Register between 2005 and 2011, were included (5,118 visits by 941 patients). We performed association analyses between various noncomposite disease activity measures at each visit and the number of days of sick leave during the subsequent month; this information was retrieved from the Social Insurance Agency. Adjusted separate generalized estimating equation regression models were used, and analyses were stratified according to sick leave status for the month preceding each visit (no, partial, or full sick leave). Results are presented as standardized beta coefficients for comparability. RESULTS: Among modifiable noncomposite disease activity measures, patient's assessment of pain and disease activity scored on a visual analog scale (VAS) were most strongly associated with subsequent sick leave, irrespective of baseline sick leave status. Generally, measures that were more objective (swollen joint count, erythrocyte sedimentation rate, and C-reactive protein) had less impact on sick leave compared with variables that were more subjective (patient's pain and global scores on a VAS, evaluator's global assessment of disease activity on a 5-grade Likert scale, and tender joint count). CONCLUSION: Measures of disease activity that are more subjective have a greater impact on sick leave in biologics-treated patients with RA compared with variables that are more objective, suggesting a stronger focus on subjective measures when targeting work loss or intervening to reduce it.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Olofsson T, Söderling JK, Gülfe A, et al. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018. PMID: 29885037. doi:10.1002/acr.23619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。